HCG (hear.com NV) EBIT: $-12.29 Mil (TTM As of Mar. 2021)


What is hear.com NV EBIT?

hear.com NV HCG EBIT is $-12.29 Mil as of Mar. 2021.

hear.com NV's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2021 was $-7.77 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2021 was $-12.29 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. hear.com NV's annualized ROC % for the quarter that ended in Mar. 2021 was -40.61%. hear.com NV's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2021 was -94.02%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.


hear.com NV  (NAS:HCG) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

hear.com NV's annualized ROC % for the quarter that ended in Mar. 2021 is calculated as:

ROC % (Q: Mar. 2021 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2020 ) + Invested Capital (Q: Mar. 2021 ))/ count )
=-32.756 * ( 1 - 0% )/( (68.62 + 92.681)/ 2 )
=-32.756/80.6505
=-40.61 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2021) data.

2. Joel Greenblatt's definition of Return on Capital:

hear.com NV's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2021 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2021 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2020  Q: Mar. 2021
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-31.06/( ( (11.822 + max(15.074, 0)) + (11.482 + max(27.693, 0)) )/ 2 )
=-31.06/( ( 26.896 + 39.175 )/ 2 )
=-31.06/33.0355
=-94.02 %

where Working Capital is:

Working Capital(Q: Dec. 2020 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(36.97 + 12.905 + 5.892) - (27.837 + 0 + 12.856)
=15.074

Working Capital(Q: Mar. 2021 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(39.71 + 14.725 + 12.449) - (19.929 + 0 + 19.262)
=27.693

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2021) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

hear.com NV's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2021 )
=-12.292/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


hear.com NV EBIT Related Terms


hear.com NV EBIT Historical Data

* Premium members only.

The historical data trend for hear.com NV's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

hear.com NV EBIT Chart

hear.com NV Annual Data
Trend Sep18 Sep19 Sep20
EBIT
0.00 -13.53 -18.64

hear.com NV Quarterly Data
Sep19 Dec19 Mar20 Sep20 Dec20 Mar21
EBIT Get a 7-Day Free Trial -4.70 -5.06 0.00 -4.53 -7.77

HCG vs : EBIT Comparison

For the Medical Devices subindustry, hear.com NV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


hear.com NV EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, hear.com NV's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where hear.com NV's EV-to-EBIT falls into.



hear.com NV EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-12.29 Mil mean?
hear.com NV (HCG) has a EBIT of $-12.29 Mil as of Mar. 2021. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on hear.com NV.
Is hear.com NV's EBIT too high?
hear.com NV's current EBIT is $-12.29 Mil.
How does hear.com NV's EBIT compare to ?
hear.com NV's EBIT of $-12.29 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on hear.com NV. hear.com NV's current EBIT is $-12.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is hear.com NV stock overvalued right now?
hear.com NV (HCG) has a current EBIT of $-12.29 Mil. The current EBIT is $-12.29 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For hear.com NV (HCG), the current EBIT is $-12.29 Mil as of Mar. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

hear.com NV Business Description

Comparable Companies
hear.com NV is a global leader in the hearing aid industry, It provides the most comprehensive care for all your hearing needs.